Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 11Unknown 3Recruiting 3Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 580Neoplasms 487Prostatic Neoplasms 311Lung Neoplasms 238Colorectal Neoplasms 201Motor Activity 131Carcinoma, Non-Small-Cell Lung 117Uterine Cervical Neoplasms 112Brain Neoplasms 110Pancreatic Neoplasms 108Head and Neck Neoplasms 106Stomach Neoplasms 99Carcinoma, Hepatocellular 99Rectal Neoplasms 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 67Multiple Myeloma 65Esophageal Neoplasms 65Hematologic Neoplasms 61Urinary Bladder Neoplasms 60Glioblastoma 59Melanoma 58Sarcoma 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Endometrial Neoplasms 56Glioma 53Lymphoma 50Leukemia, Myeloid, Acute 48Gastrointestinal Neoplasms 48

Interventions

Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Patient Acceptance of Health Care × Clear all
NCT07024329 2026-04-30

RESPONd

University of Calgary

Phase NA Recruiting
1,055 enrolled

Neoplasms, Patient Acceptance of Health Care

NCT06326567 2025-04-06

Comprehensive Connected Cancer Care (C4): Intervention Evaluation

University of Kentucky

Phase NA Recruiting
300 enrolled

Neoplasms, Patient Acceptance of Health Care

NCT06436157 2025-01-31

GENESIS

University of California, Davis

Phase NA Recruiting
60 enrolled

Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon âš¡